Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
BETOPTIC S betaxolol 0.25% 2.5 mg/mL (as hydrochloride) eye drops suspension bottle, Novartis Pharmaceuticals Australia Pty Ltd, CON-212
Product name
BETOPTIC S betaxolol 0.25% 2.5 mg/mL (as hydrochloride) eye drops suspension bottle
Sponsor name
Novartis Pharmaceuticals Australia Pty Ltd
ARTG
42900
Consent start
Consent no.
CON-212
Standard
Subclause 3(2)(l) of the Therapeutic Goods Order No. 69
Non-compliance with standard
The product labels do not bear current sponsors name and address.
Conditions imposed
The labels to which this consent applies are those approved under
Therapeutic Goods Order No .69 for the former sponsor Alcon Laboratories
(Australia) Pty Ltd and arrangements are in place to redirect any correspondence
to current sponsor Novartis Pharmaceuticals Australia Pty Ltd.
Therapeutic product type
Prescription medicines